Dowlati A - Search Results

1

Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

Ganti AKP, Loo BW, Bassetti M, Blakely C, Chiang A, D'Amico TA, D'Avella C, Dowlati A, Downey RJ, Edelman M, Florsheim C, Gold KA, Goldman JW, Grecula JC, Hann C, Iams W, Iyengar P, Kelly K, Khalil M, Koczywas M, Merritt RE, Mohindra N, Molina J, Moran C, Pokharel S, Puri S, Qin A, Rusthoven C, Sands J, Santana-Davila R, Shafique M, Waqar SN, Gregory KM, Hughes M. Ganti AKP, et al. Among authors: dowlati a. J Natl Compr Canc Netw. 2021 Dec;19(12):1441-1464. doi: 10.6004/jnccn.2021.0058. J Natl Compr Canc Netw. 2021. PMID: 34902832 Free PMC article.

2

Phase II trial of thalidomide as maintenance therapy for extensive stage small cell lung cancer after response to chemotherapy.

Dowlati A, Subbiah S, Cooney M, Rutherford K, Mekhail T, Fu P, Chapman R, Ness A, Cortas T, Saltzman J, Levitan N, Warren G. Dowlati A, et al. Lung Cancer. 2007 Jun;56(3):377-81. doi: 10.1016/j.lungcan.2007.01.020. Epub 2007 Feb 27. Lung Cancer. 2007. PMID: 17328989 Clinical Trial.

3

Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501.

Horn L, Dahlberg SE, Sandler AB, Dowlati A, Moore DF, Murren JR, Schiller JH. Horn L, et al. Among authors: dowlati a. J Clin Oncol. 2009 Dec 10;27(35):6006-11. doi: 10.1200/JCO.2009.23.7545. Epub 2009 Oct 13. J Clin Oncol. 2009. PMID: 19826110 Free PMC article. Clinical Trial.

4

Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer.

Ross HJ, Blumenschein GR Jr, Aisner J, Damjanov N, Dowlati A, Garst J, Rigas JR, Smylie M, Hassani H, Allen KE, Leopold L, Zaks TZ, Shepherd FA. Ross HJ, et al. Among authors: dowlati a. Clin Cancer Res. 2010 Mar 15;16(6):1938-49. doi: 10.1158/1078-0432.CCR-08-3328. Epub 2010 Mar 9. Clin Cancer Res. 2010. PMID: 20215545 Clinical Trial.

5

Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.

Hubbard MO, Fu P, Margevicius S, Dowlati A, Linden PA. Hubbard MO, et al. Among authors: dowlati a. J Thorac Cardiovasc Surg. 2012 Jun;143(6):1307-13. doi: 10.1016/j.jtcvs.2012.01.078. Epub 2012 Feb 22. J Thorac Cardiovasc Surg. 2012. PMID: 22361247 Free article.

6

Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer.

Schwandt A, Mekhail T, Halmos B, O'Brien T, Ma PC, Fu P, Ivy P, Dowlati A. Schwandt A, et al. Among authors: dowlati a. J Thorac Oncol. 2012 Apr;7(4):751-4. doi: 10.1097/JTO.0b013e31824abca2. J Thorac Oncol. 2012. PMID: 22425925 Free PMC article. Clinical Trial.

7

PIAS3 activates the intrinsic apoptotic pathway in non-small cell lung cancer cells independent of p53 status.

Dabir S, Kluge A, McColl K, Liu Y, Lam M, Halmos B, Wildey G, Dowlati A. Dabir S, et al. Among authors: dowlati a. Int J Cancer. 2014 Mar 1;134(5):1045-54. doi: 10.1002/ijc.28448. Epub 2013 Sep 23. Int J Cancer. 2014. PMID: 23959540 Free PMC article.

8

Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer.

Sharma N, Pennell N, Nickolich M, Halmos B, Ma P, Mekhail T, Fu P, Dowlati A. Sharma N, et al. Among authors: dowlati a. Invest New Drugs. 2014 Apr;32(2):362-8. doi: 10.1007/s10637-013-0061-6. Epub 2014 Jan 15. Invest New Drugs. 2014. PMID: 24420556 Clinical Trial.

9

Clinical trial design in small cell lung cancer: surrogate end points and statistical evolution.

Nickolich M, Babakoohi S, Fu P, Dowlati A. Nickolich M, et al. Among authors: dowlati a. Clin Lung Cancer. 2014 May;15(3):207-12. doi: 10.1016/j.cllc.2013.12.001. Epub 2013 Dec 27. Clin Lung Cancer. 2014. PMID: 24485231

10

Defining subgroups of small-cell lung cancer.

Dowlati A, Wildey G. Dowlati A, et al. J Thorac Oncol. 2014 Jun;9(6):750-1. doi: 10.1097/JTO.0000000000000176. J Thorac Oncol. 2014. PMID: 24828659 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page